Quote | Super Quote
Future News

16/11/2026 12:22

HSI rises 197 points to 23835 in morning session; New World plunges nearly 40% on rights issue plan, CanSinoBiologics hit by core drug setback

    {Econews Communication Agency, November 16} China's latest data for October on the three major economic drivers all missed expectations. Industrial value-added increased 4.8% year-on-year in October, retail sales of consumer goods rose only 0.4% year-on-year in the month, while fixed asset investment declined 8.1% year-on-year in the first 10 months. Despite the underwhelming data, expectations are rising for economic stimulus measures to be announced at next month's Politburo meeting and the Central Economic Work Conference. Supported by pre-earnings strength in tech stocks, the Hang Seng Index rose 197 points or 0.8% in the morning session to 23835, with main board turnover exceeding HK$90.7 billion. The Hang Seng China Enterprises Index rose 63 points or 0.8% to 8001. The Hang Seng Tech Index gained 20 points or 0.5% to 3833.

    Tech stocks rebounded, with Baidu (09888) up 2.76% at HK$76.25 ahead of its earnings release today, Alibaba (09988) up 1.05% at HK$91.5, Tencent (00700) up 1.97% at HK$394.2, Meituan (03690) up 3.37% at HK$72.15, and JD.com (09618) up 1.78% at HK$108.9.

    Overseas semiconductor stocks continued to be sold off, with Japanese equities down 1.9% and South Korean equities down 2.9%. Hong Kong's AI hardware sector remained weak, with Lenovo Group (00992) down 4.2% at HK$16.88, Hua Hong Semiconductor (01347) down 0.69% at HK$71.8, SMIC (00981) down 2.02% at HK$47.54, Kingboard Laminates (01888) down 3.32% at HK$25.6, hitting a six-month low, and Yangtze Optical Fibre and Cable (06869) plunging 7.29% to HK$82.05.

    China's retail sales of consumer goods rose 0.4% year-on-year in October, below the market forecast median of 0.8%. Hopes for stimulus measures to boost domestic consumption supported consumer stocks this morning, with Haidilao (06862) up 4.84% at HK$10.4, Mengniu Dairy (02319) up 4.01% at HK$22.8, China Resources Beer (00291) up 3.32% at HK$21.14, and WH Group (00288) up 2.66% at HK$6.945.

    New World (00017) proposed a '1 for 11' rights issue, causing its share price to plunge 38.5% in the morning session to HK$2.995.

    Summit Therapeutics, CanSinoBiologics' (09926) U.S. partner, announced on November 15 that it had received a Complete Response Letter from the U.S. Food and Drug Administration (FDA), temporarily rejecting the first U.S. marketing application for CanSino's core drug, Ivascirna. CanSinoBiologics fell 23.27% in the morning session to HK$63.15.

    Sands China (01928) rose 4.12% to HK$11.11, while Galaxy Entertainment (00027) gained 1.26% to HK$33.84.

    Apple-related blue chips led the declines, with BYD Electronic (00285) down 4.84% at HK$18.68, and Sunny Optical Technology (02382) down 3.11% at HK$63.8.

    The top three most actively traded stocks in the Hang Seng Index were Tencent, Alibaba, and SMIC. The top three in the China Enterprises Index were Tencent, Alibaba, and CanSinoBiologics. The top three in the Tech Index were Tencent, Alibaba, and Zhipu (02513), with Zhipu closing at HK$362.8, down 11.2%. (ey)
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.